AB Science S.A.
ABSCFOTCHealthcare● Active
$1.12
+$0.00(+0.00%)
Market Cap$78149344
P/E Ratio—
52W High$2.7
52W Low$1.12
AB Science S.A. (ABSCF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ABSCF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.17M | $1.07M | $0.97M | $0.96M | $1.61M |
| Cost of Revenue | $0.45M | ($0.18M) | $0.38M | $0.03M | $0.11M |
| Gross Profit | $0.72M | $1.25M | $0.59M | $0.93M | $1.50M |
| Gross Margin %(computed) | 61.33% | 116.42% | 60.52% | 96.76% | 93.09% |
| Operating Expenses | |||||
| R&D Expenses | ($0.23M) | $3.94M | $13.93M | $13.35M | $11.23M |
| G&A Expenses | $0.00M | $1.81M | $3.02M | $1.87M | $3.58M |
| Total Operating Expenses | $1.94M | $7.33M | $14.02M | $16.86M | $15.30M |
| Operating Income | ($1.22M) | ($6.08M) | ($13.43M) | ($15.94M) | ($13.81M) |
| Operating Margin %(computed) | -103.66% | -567.44% | — | — | -859.24% |
| Interest Income | $0.24M | $0.00M | $2.65M | $1.07M | $0.89M |
| Interest Expense | $1.41M | $2.25M | $3.96M | $2.02M | $1.28M |
| Income Before Tax | ($3.41M) | ($7.83M) | ($11.98M) | ($13.61M) | ($14.43M) |
| Income Tax Expense | ($1.86M) | $0.00M | $0.00M | $0.00M | $0.04M |
| Net Income | ($1.56M) | ($7.83M) | ($11.98M) | ($13.62M) | ($14.46M) |
| Net Margin %(computed) | -132.62% | -730.50% | — | — | -900.00% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.03 | $-0.15 | $-0.24 | $-0.29 | $-0.30 |
| Wtd Avg Shares | 61.24M | 53.27M | 49.66M | 47.14M | 47.52M |
| EBITDA | ($0.96M) | ($4.92M) | ($12.80M) | ($15.53M) | ($12.65M) |
| EBITDA Margin %(computed) | -81.69% | -458.68% | — | — | -787.18% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · EUR · M
Explore more AB Science S.A. data
About AB Science S.A. (ABSCF) Income Statement
AB Science S.A. (ABSCF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ABSCF reported revenue of $0.00B, gross profit of $0.00B (gross margin 61.33%), and net income of ($0.00B) — a net profit margin of -132.62%.
Frequently asked questions
ABSCF · 4 questionsAB Science S.A. (ABSCF) reported revenue of $0.00B for 2025, up 9.5% year-over-year.
ABSCF revenueABSCF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09